TY - JOUR
T1 - Characterization of West African Crystalline Macular Dystrophy in the Ghanaian Population
AU - Ghana AMD Study Group
AU - Amoaku, Winfried M.
AU - Sampalli, Amrit
AU - Silvestri, Vittorio
AU - Cushley, Laura N.
AU - Akafo, Stephen
AU - Amissah-Arthur, Kwesi N.
AU - Lartey, Seth
AU - Hageman, Courtney N.
AU - Hubbard, William C.
AU - Pappas, Chris M.
AU - Zouache, Moussa A.
AU - Stevenson, Michael
AU - Hageman, Gregory S.
AU - Silvestri, Giuliana
N1 - Publisher Copyright:
© 2022 American Academy of Ophthalmology
PY - 2022/8
Y1 - 2022/8
N2 - Objective: West African crystalline maculopathy (WACM) is characterized by the presence of macular hyperrefractile crystal-like deposits. Although the underlying pathophysiology has not been elucidated, a few biologic drivers have been proposed. We analyzed a large WACM case series to gain a more robust understanding of its features and etiology. Design: Prospective, cross-sectional cohort study. Subjects: Participants with WACM were selected from the large cohort recruited in the Ghana Age-Related Macular Degeneration Study. Methods: Demographic and detailed medical histories, full ophthalmic examinations, digital color fundus photographs, and OCT images were obtained. All cases with WACM were evaluated by 3 retina experts. Crystal numbers, location, and distribution were determined. Associations between WACM and White age-related macular degeneration (AMD) risk variants were assessed using Firth's bias-reduced logistic regression, including age and sex as covariates. Main Outcome Measures: Phenotypic features of, and genetic associations with, WACM. Results: West African crystalline maculopathy was identified in 106 eyes of 53 participants: 22 were bilateral and 24 were unilateral. Grading for AMD was not possible in 1 eye in 7 participants with WACM; therefore, laterality was not assessed in these subjects. Thirty-eight participants were women and were 14 men; sex was unrecorded for 1 participant. The mean age was 68.4 years (range, 45–101 years). Typical WACM crystals were demonstrated on OCT, which were more easily identified at high contrast and predominantly located at the inner limiting membrane. In eyes with copathology, crystals localized deeper in the inner retina, with wider retinal distribution over copathology lesions. There was no association with age or sex. A significant association was observed between the complement factor H (CFH) 402H risk variant and WACM. Conclusions: This study confirms the localization of crystals adjacent to the inner limiting membrane and distribution over lesions in eyes with copathology. The evaluation of OCT images under high contrast allows improved identification. West African crystalline maculopathy may be associated with the CFH-CFHR5 AMD risk locus identified among Whites; however, it is also possible that the combination of crystals and the CFH 402H allele increases the risk for developing late AMD. Further analyses using larger sample sizes are warranted to identify causalities between genotype and WACM phenotype.
AB - Objective: West African crystalline maculopathy (WACM) is characterized by the presence of macular hyperrefractile crystal-like deposits. Although the underlying pathophysiology has not been elucidated, a few biologic drivers have been proposed. We analyzed a large WACM case series to gain a more robust understanding of its features and etiology. Design: Prospective, cross-sectional cohort study. Subjects: Participants with WACM were selected from the large cohort recruited in the Ghana Age-Related Macular Degeneration Study. Methods: Demographic and detailed medical histories, full ophthalmic examinations, digital color fundus photographs, and OCT images were obtained. All cases with WACM were evaluated by 3 retina experts. Crystal numbers, location, and distribution were determined. Associations between WACM and White age-related macular degeneration (AMD) risk variants were assessed using Firth's bias-reduced logistic regression, including age and sex as covariates. Main Outcome Measures: Phenotypic features of, and genetic associations with, WACM. Results: West African crystalline maculopathy was identified in 106 eyes of 53 participants: 22 were bilateral and 24 were unilateral. Grading for AMD was not possible in 1 eye in 7 participants with WACM; therefore, laterality was not assessed in these subjects. Thirty-eight participants were women and were 14 men; sex was unrecorded for 1 participant. The mean age was 68.4 years (range, 45–101 years). Typical WACM crystals were demonstrated on OCT, which were more easily identified at high contrast and predominantly located at the inner limiting membrane. In eyes with copathology, crystals localized deeper in the inner retina, with wider retinal distribution over copathology lesions. There was no association with age or sex. A significant association was observed between the complement factor H (CFH) 402H risk variant and WACM. Conclusions: This study confirms the localization of crystals adjacent to the inner limiting membrane and distribution over lesions in eyes with copathology. The evaluation of OCT images under high contrast allows improved identification. West African crystalline maculopathy may be associated with the CFH-CFHR5 AMD risk locus identified among Whites; however, it is also possible that the combination of crystals and the CFH 402H allele increases the risk for developing late AMD. Further analyses using larger sample sizes are warranted to identify causalities between genotype and WACM phenotype.
KW - Crystalline
KW - Genetic associations
KW - OCT
KW - Optical coherence tomography
KW - WACM
KW - West African Crystalline Dystrophy
UR - http://www.scopus.com/inward/record.url?scp=85128234827&partnerID=8YFLogxK
U2 - 10.1016/j.oret.2022.03.006
DO - 10.1016/j.oret.2022.03.006
M3 - Article
C2 - 35307605
AN - SCOPUS:85128234827
SN - 2468-6530
VL - 6
SP - 723
EP - 731
JO - Ophthalmology Retina
JF - Ophthalmology Retina
IS - 8
ER -